Key facts
- This page summarizes Joel David Mayersohn's Form 5 filing for QSAM Biosciences, Inc..
- 2 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2022, 20:57.
Joel David Mayersohn - 31 Dec 2021 Form 5 Insider Report for QSAM Biosciences, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 31 Dec 2021
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 14 Feb 2022, 20:57:28 UTC
- Next SEC filing
- 13 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joel Mayersohn
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joel David Mayersohn filed Form 5 for QSAM Biosciences, Inc. on 14 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QSAM
transaction
COMMON STOCK
Award
- Transaction value
- $0
- Shares
- +400,000
- Change %
- Price
- $0.000000
- Shares after
- 400,000
- Date
- 15 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
QSAM
holding
COMMON STOCK
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 428,616
- Date
- 31 Dec 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QSAM
transaction
Derivative
Options to buy common stock
Award
- Transaction value
- $0
- Shares
- +54,000
- Change %
- Price
- $0.000000
- Shares after
- 54,000
- Date
- 24 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 54,000
- Exercise price
- $0.3600
- Footnotes
- F3
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 37,840
- Date
- 31 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,840
- Exercise price
- $0.5000
- Footnotes
- F4
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 40,000
- Date
- 31 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $0.5000
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
This award of shares was made pursuant to Issuer's board of director's approval under Issuer's restricted stock agreement.
Footnote F2
The total holdings reported on previous Form 5 accidentally included 39,760 shares of common stock that Mr. Mayersohn did not hold.
Footnote F3
The options vest semi-annually in two equal installments beginning on 02/24/2022.
Footnote F4
The total holdings reported on previous Form 5 accidentally reported 2000 less options to buy common stock of the Company.